Literature DB >> 27685334

Fluorescent Orthotopic Mouse Model of Pancreatic Cancer.

Jonathan A Moreno1, Antonio Sanchez2, Robert M Hoffman3, Saima Nur1, Maria P Lambros4.   

Abstract

Pancreatic cancer remains one of the cancers for which survival has not improved substantially in the last few decades. Only 7% of diagnosed patients will survive longer than five years. In order to understand and mimic the microenvironment of pancreatic tumors, we utilized a murine orthotopic model of pancreatic cancer that allows non-invasive imaging of tumor progression in real time. Pancreatic cancer cells expressing green fluorescent protein (PANC-1 GFP) were suspended in basement membrane matrix, high concentration, (e.g., Matrigel HC) with serum-free media and then injected into the tail of the pancreas via laparotomy. The cell suspension in the high concentration basement membrane matrix becomes a gel-like substance once it reaches room temperature; therefore, it gels when it comes in contact with the pancreas, creating a seal at the injection site and preventing any cell leakage. Tumor growth and metastasis to other organs are monitored in live animals by using fluorescence. It is critical to use the appropriate filters for excitation and emission of GFP. The steps for the orthotopic implantation are detailed in this article so researchers can easily replicate the procedure in nude mice. The main steps of this protocol are preparation of the cell suspension, surgical implantation, and whole body fluorescent in vivo imaging. This orthotopic model is designed to investigate the efficacy of novel therapeutics on primary and metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27685334      PMCID: PMC5092057          DOI: 10.3791/54337

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

1.  Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice.

Authors:  Michael P Kim; Douglas B Evans; Huamin Wang; James L Abbruzzese; Jason B Fleming; Gary E Gallick
Journal:  Nat Protoc       Date:  2009-10-29       Impact factor: 13.491

Review 2.  Management of borderline resectable pancreatic cancer.

Authors:  Amit Mahipal; Jessica Frakes; Sarah Hoffe; Richard Kim
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

3.  Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.

Authors:  Michael Bouvet; Jinwei Wang; Stephanie R Nardin; Rounak Nassirpour; Meng Yang; Eugene Baranov; Ping Jiang; A R Moossa; Robert M Hoffman
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

4.  Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts.

Authors:  Robert M Hoffman
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

5.  Diagnosis and management of pancreatic cancer.

Authors:  Maria Syl D De La Cruz; Alisa P Young; Mack T Ruffin
Journal:  Am Fam Physician       Date:  2014-04-15       Impact factor: 3.292

Review 6.  The multiple uses of fluorescent proteins to visualize cancer in vivo.

Authors:  Robert M Hoffman
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

7.  Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer.

Authors:  Matthew H Katz; Michael Bouvet; Shinako Takimoto; Daniel Spivack; Abdool R Moossa; Robert M Hoffman
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

Review 8.  Maximizing mouse cancer models.

Authors:  Kristopher K Frese; David A Tuveson
Journal:  Nat Rev Cancer       Date:  2007-09       Impact factor: 60.716

9.  Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel.

Authors:  Yong-Jian Jiang; Chong-Lek Lee; Qiang Wang; Zhong-Wen Zhou; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 10.  Advances in optical imaging for pharmacological studies.

Authors:  Alicia Arranz; Jorge Ripoll
Journal:  Front Pharmacol       Date:  2015-09-11       Impact factor: 5.810

View more
  1 in total

1.  Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.

Authors:  Lian-Yu Chen; Chien-Shan Cheng; Chao Qu; Peng Wang; Hao Chen; Zhi-Qiang Meng; Zhen Chen
Journal:  Int J Mol Sci       Date:  2018-06-14       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.